ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Recalls and Alerts

Class 4 Caution in Use

Class 4 caution in use-Irbesartan 150mg & 300mg Tablets

Jubilant Pharmaceuticals NV has informed the MHRA that the Patient information leaflet (PIL) in the cartons for the batches listed in this notification include an outdated PIL.

 

MHRA Drug alert date: 13th January 2025

 

MHRA Drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-notification-irbesartan-150-mg-and-300-mg-film-coated-tablets-el-25-a-slash-02?utm_medium=email&utm_campaign=govuk-notifications-topic&utm_source=ba29731f-c857-4e43-9347-5e2d5baeafc8&utm_content=immediately

 

Pip code

Product description

Supplier

Batch Numbers

6359624

IRBESARTAN TAB 150MG

Jubilant Pharmaceuticals

SEE ABOVE LINK

6359608

IRBESARTAN TAB 300MG

Jubilant Pharmaceuticals

SEE ABOVE LINK

 

This is a caution in use only we are not accepting stock returns

 

Further Information

For medical information enquiries please contact: safety.uk@lambda-cro.com, Telephone number: 0080089013370

 

For stock control enquiries please contact: JPUK.Customerservice@jubl.com, Telephone: +4401233 552293